The build-out of a comprehensive regulatory framework for payment stablecoins is steadily moving toward completion, as the various agencies ...

The company said the independent safety board reviewing the study saw a clear trend favoring the Annamycin combination, though there was no statistical significance. ・Full data from the first part of ...

Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control ...

Close to a third of firms inspected by the Solicitors Regulation Authority (SRA) were found non-compliant. AMLCC’s Richard Simms explains what inspectors look for and how to ensure your firm is ready.

The Treasury Department is guiding banks to share information on suspected undocumented customers, framing it as a crackdown on fraud and crime. New guidance allows banks to rapidly share data and ...

Survival outcomes were favorable post-ASCT, with 90% 1- and 2-year OS, 82% 1-year EFS, and low nonrelapse mortality (4%), in a cohort enriched for KMT2Ar AML. Landmark comparisons suggested reduced ...

Acute Myeloid Leukemia (AML) is a rare and aggressive blood cancer. The earliest sign of AML is often feeling very tired. Certain risk factors like smoking and being over 65 can increase the chances ...

Cancer Res (2026) 86 (7_Supplement): 2495. Waiting for test results is a primary cause of delay in the diagnostic classification and risk stratification of patients with AML. With conventional ...

Some legal and accountancy regulators are not undertaking “sufficiently dissuasive disciplinary measures” over non-compliance with anti-money laundering (AML) rules, their oversight body has warned.

Acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) are blood cell cancers that start in the bone marrow. AML is more common and more aggressive than CML. AML is usually treated with ...

This manuscript provides a single-cell transcriptomic atlas for AML (222 samples comprising 748,679 cells) integrating data from multiple studies. They use this dataset to investigate t(8;21) AML, and ...

Reduced venetoclax doses or shorter durations maintain efficacy and improve outcomes in unfit AML patients by enhancing treatment persistence. Modified venetoclax regimens showed higher complete ...